Etienne Sochett
Overview
Explore the profile of Etienne Sochett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
896
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
West S, Furman M, Moineddin R, Sochett E
Bone Rep
. 2024 Nov;
23:101813.
PMID: 39611164
Purpose: Physical activity (PA) is an important determinant of skeletal health. In young adults with type 1 diabetes (T1D) fracture risk is increased, yet few studies have examined the PA...
2.
White C, Gaynor-Sodeifi K, Norman P, Furman M, Sochett E
Kidney360
. 2024 Jul;
5(8):1178-1185.
PMID: 39008636
No abstract available.
3.
Ward L, Hogler W, Glorieux F, Portale A, Whyte M, Munns C, et al.
JBMR Plus
. 2024 May;
8(1):ziad001.
PMID: 38690124
In a randomized, open-label phase 3 study of 61 children aged 1-12 years old with X-linked hypophosphatemia (XLH) previously treated with conventional therapy, changing to burosumab every 2 weeks (Q2W)...
4.
Imel E, Glorieux F, Whyte M, Portale A, Munns C, Nilsson O, et al.
J Clin Endocrinol Metab
. 2023 Apr;
108(11):2990-2998.
PMID: 37084401
Context: In an open-label, randomized, controlled, phase 3 trial in 61 children aged 1 to 12 years with X-linked hypophosphatemia (XLH), burosumab improved rickets vs continuing conventional therapy with active...
5.
Lenherr-Taube N, Furman M, Assor E, Thummel K, Levine M, Sochett E
J Steroid Biochem Mol Biol
. 2023 Mar;
231:106301.
PMID: 36990163
Idiopathic Infantile Hypercalcemia (IIH) is characterized by hypercalcemia and hypercalciuria owing to PTH-independent increases in circulating concentrations of 1,25(OH)2D. At least 3 forms of IHH can be distinguished genetically and...
6.
Malcolmson C, Lautatzis M, Malkiel S, Lenherr-Taube N, Traubici J, Gupta A, et al.
J Pediatr Hematol Oncol
. 2022 Jan;
44(3):e782-e787.
PMID: 35091517
Osteosarcoma is the most common pediatric malignant bone tumor. Concomitant osteoporosis has typically been attributed to oncologic therapy. The present case series is aimed to describe 3 patients who presented...
7.
Lenherr-Taube N, Furman M, Assor E, Elia Y, Collins C, Thummel K, et al.
J Clin Endocrinol Metab
. 2021 Jun;
106(10):2938-2948.
PMID: 34139759
Context: Idiopathic infantile hypercalcemia (IIH) is an uncommon disorder with variable clinical features. The natural history and response to dietary calcium and vitamin D restriction in IIH remains unclear. Objective:...
8.
Lenherr-Taube N, Young E, Furman M, Elia Y, Assor E, Chitayat D, et al.
J Clin Endocrinol Metab
. 2021 Jun;
106(10):2915-2937.
PMID: 34125233
Context: Idiopathic infantile hypercalcemia (IIH), an uncommon disorder characterized by elevated serum concentrations of 1,25 dihydroxyvitamin D (1,25(OH)2D) and low parathyroid hormone (PTH) levels, may present with mild to severe...
9.
Padidela R, Whyte M, Glorieux F, Munns C, Ward L, Nilsson O, et al.
Calcif Tissue Int
. 2021 Jan;
108(5):622-633.
PMID: 33484279
Changing to burosumab, a monoclonal antibody targeting fibroblast growth factor 23, significantly improved phosphorus homeostasis, rickets, lower-extremity deformities, mobility, and growth versus continuing oral phosphate and active vitamin D (conventional...
10.
Sullivan K, Scholey J, Moineddin R, Sochett E, Wicklow B, Elia Y, et al.
Diabetologia
. 2020 Nov;
64(2):476.
PMID: 33146765
No abstract available.